Ocular Therapeutix (OCUL) Net Equity Issued and Repurchased (2013 - 2026)
Ocular Therapeutix's Net Equity Issued and Repurchased was $1.68 million in Q2 2026, down 45.3% from $3.07 million a year earlier but up 471.1% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ocular Therapeutix's Net Equity Issued and Repurchased was $15.27 million through Jun 30, 2026, up 110.5% year-over-year; for FY2025, it came in at $20.54 million, down 93.5% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -38.0% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $316.35 million in FY2024, $851,000 in FY2023 (-9.5%), $940,000 in FY2022 (-63.7%) and $2.59 million in FY2021 (-98.8%).
- Quarterly Net Equity Issued and Repurchased has moved between -$8.68 million (Q4 2023) and $316.35 million (Q1 2024) over five years.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2022 (growth of 147.7%); the worst was Q4 2021 (a decline of 99.9%).
- Per Business Quant data, OCUL's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $294,000 (Q1 2026), $2.94 million (Q4 2025) and $10.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.56 Bn | 1,136.14 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 635.76 Bn | 554.29 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 503.27 Bn | 476.38 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 377.51 Bn | 331.89 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 304.07 Bn | 268.06 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.22 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 242.06 Bn | 197.46 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.26 Bn | 168.46 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.62 Bn | 119.27 Bn | 10.94 Bn | - |
| 10 | Ocular Therapeutix | 1.49 Bn | -861.36 Mn | 11.46 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 449.38 Mn |
| Sep 30, 2025 | 10.36 Mn |
| Jun 30, 2025 | 97.81 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 4.18 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 321.22 Mn |
| Dec 31, 2023 | 108.17 Mn |
| Sep 30, 2023 | 770,000.00 |
| Jun 30, 2023 | 9.65 Mn |
| Mar 31, 2023 | 78,000.00 |
| Dec 31, 2022 | 458,000.00 |
| Sep 30, 2022 | 374,000.00 |
| Jun 30, 2022 | 493,000.00 |
| Mar 31, 2022 | 129,000.00 |
| Dec 31, 2021 | 667,000.00 |
| Sep 30, 2021 | 679,000.00 |
API Access
Ocular Therapeutix Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();